No official agreement or mou to distribute the vaccines for general public. Inix is only distributing the vaccines for clinical trial only. Part of their CSR initiative.
Glove production line started, going to increase every months, this counters is no more pure speculative but with strong earning prospects. And being a goreng stock is actually a surplus point to enter, better than those sleeping counter right...who knows next day it hits limit up again ler hahaha...
sorry.. im not negative person... i think bombibi still not so rite.. coz is write there help to source.. then mention few china vaccine... but china got so many lab research for covid vaccine... i dun think to help bring in for trial... is help to source only...
Reference is made to the Company’s announcement made on 13 January 2021 and 20 January 2021.
For clarification, the Board of Directors of INIX wishes to inform that Inix Network Sdn Bhd was appointed as distributors for the Covid-19 vaccine by Sinovac Biotech Co Ltd, Cansino Biologics Inc and Sinopharm China National Biotech Group Co Ltd on 28 October 2020.
@dragon_loong Distribution here refers to distribution of vaccine for clinical trial participants, not distribution of vaccine for general public use. Inix will sponsor the vaccines for use in the clinical trial as part of their CORPORATE SOCIAL RESPONSIBILITY (CSR) INITIATIVE.
Read until the end, especially the last paragrah of the 1st announcement. The hint is there.
“ As and when iNix has received the approval from MoH, iNix would be able to import the vaccine and supply the same to MoH to conduct 3rd Phase Clinical Trial in which it would be fully sponsored by iNix as INIX’s CSR initiative. This first clinical trial in Malaysia is expected to involve approximately 3,000 volunteers.”
The “approval” here refers to the approval to import the vaccine for purpose of clinical trial only and not approval for general public use in Malaysia. Otherwise why do you still need to conduct clinical trials when the approval of the vaccine by MOH is for general public use? Inix is playing around with words here to confuse and mislead the shareholders.
Besides, there is no MOU or official distributor agreement between Sinovac, Cansino and Sinopharm with Inix. Otherwise, it would have been announced in Bursa Malaysia.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
HosehLim80
295 posts
Posted by HosehLim80 > 2021-01-21 17:58 | Report Abuse
This stock has any fundamental? Look like goreng goreng only